tenofovir has been researched along with Birth Weight in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, R; Desmond, AC; Govender, V; Gray, G; Lombard, C; Mhlongo, O; Moodley, D; Naidoo, K; Naidoo, M; Newell, ML; Rooney, JF; Sebitloane, M | 1 |
| Cai, HD; Cao, YJ; Hu, YH; Liu, M; Yi, W | 1 |
| John-Stewart, G; Katana, A; Kinuthia, J; Langat, A; McGrath, CJ; Nganga, L; Odeny, B; Pintye, J; Singa, B | 1 |
| Bunders, MJ; Cohen, S; Denneman, L; Godfried, MH; Kuijpers, TW; Nellen, JF; Pajkrt, D; Scherpbier, HJ; Smit, C; van de Plas, A; van Leeuwen, E; Weijsenfeld, AM | 1 |
| Anderson, JR; Doherty, MC; Essajee, S; Ford, N; Kanters, S; Mills, EJ; Mofenson, LM; Nachega, JB; Renaud, F; Uthman, OA | 1 |
1 review(s) available for tenofovir and Birth Weight
| Article | Year |
|---|---|
Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
Topics: Anti-HIV Agents; Birth Weight; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Safety; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Tenofovir | 2017 |
1 trial(s) available for tenofovir and Birth Weight
| Article | Year |
|---|---|
Pregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trial.
Topics: Adenine; Anti-HIV Agents; Birth Weight; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Pre-Exposure Prophylaxis; Pregnancy; Premature Birth; South Africa; Stillbirth; Tenofovir; Treatment Outcome | 2023 |
3 other study(ies) available for tenofovir and Birth Weight
| Article | Year |
|---|---|
Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
Topics: Adenine; Adult; Antiviral Agents; Apgar Score; Biomarkers; Birth Weight; China; DNA, Viral; Drug Resistance, Viral; Drug Substitution; Female; Genotype; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Live Birth; Male; Middle Aged; Mutation; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome; Vaccination; Viral Load; Young Adult | 2015 |
Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya.
Topics: Adult; Anti-HIV Agents; Antibiotic Prophylaxis; Birth Weight; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Tenofovir; Young Adult | 2015 |
In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.
Topics: Anti-HIV Agents; Birth Weight; Child Development; Female; Fetal Development; Fetal Growth Retardation; Follow-Up Studies; Growth Disorders; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Tenofovir | 2016 |